Sunshine Healthcare Lanka (SHL), the healthcare arm of the diversified Sri Lankan conglomerate Sunshine Holdings, has appointed Shantha Bandara as the Chief Executive Officer of its pharmaceutical division. The appointment came into effect on July 1.
He holds an MBA from the Postgraduate Institute of Management (PIM), University of Sri Jayewardenepura and is an Executive Committee Member of Sunshine Holdings. He joined Sunshine Healthcare in 2011 and rose through the ranks to become the COO in 2018. He has been instrumental in growing the healthcare business to be the key driver of the Group’s financial performance, helping Sunshine Holdings to sustain its growth over the last two years amidst tough macroeconomic conditions. Before joining Sunshine Healthcare, Shantha held several leadership positions.